DRUG PREDICTION PLATFORM
Dead / Abandoned — Abandoned — failure to respond (as of 18 Apr 2024)
What this means for you
This application is over — abandoned 28 Mar 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97834146
- Mark type
- Stylized text
- Filed
- 10 Mar 2023
- Abandoned
- 28 Mar 2024
- Attorney of record
- Christopher D. Casavale
Goods and services
- Class 042 — Scientific and technological services: Cancer research services; cancer drug treatment development services; cancer treatment drug development consulting services; cancer drug treatment testing services for others; Medical research services in the field of cancer
- Class 044 — Medical, beauty and agricultural services: Medical services in the field of cancer treatment; cancer treatment consulting services for cancer patients; cancer treatment services; precision therapy services; DNA sequencing services; phenotype screening services; personalized pharmacogenomics services; biomarker validation services; biotechnology services; targeted and personalized healthcare services; cancer drug treatment selection consulting services
Owner
- First Ascent Biomedical Inc., Miami, FL, US
Prosecution history
- 18 Apr 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 18 Apr 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 27 Dec 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Dec 2023 — NON-FINAL ACTION E-MAILED
- 27 Dec 2023 — NON-FINAL ACTION WRITTEN
- 07 Dec 2023 — ASSIGNED TO EXAMINER
- 31 Mar 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Mar 2023 — NEW APPLICATION ENTERED